HOME >> BIOLOGY >> NEWS
Open source and open medicine take centre stage at UN research symposium

Can an Intellectual Property regime designed to protect private interests be reformed to "lock everyone in"? What results when government authorities promote free, open source software in their jurisdictions? Who (if anyone) should own or control access to the human genome sequence? What parallels can be drawn with the fundamental principles of 'openness' for science and society as a whole?

These and a host of other issues will be explored at a research symposium titled Challenging Intellectual Property: Access to Knowledge Issues in Open Source and Medicine that takes place on Thursday 13 April 2006 at the UN Headquarters in New York. The event is organized by the United Nations University at the United Nations, New York, and United Nations University - Maastricht Economic and social Research and training centre on Innovation and Technology (UNU-MERIT) in the Netherlands.

The Symposium will analyse the role of Free/Open Source Software and other collaborative models of knowledge production in economic development. It will also assess the effectiveness of several alternative global financing mechanisms that have been proposed to boost health research and development, and broaden access to affordable drugs for the world's poorest populations.

The speakers include:

  • Rishab Aiyer Ghosh, Senior Researcher, UNU-MERIT;
  • Louis-Dominique Oudraogo, retiring Inspector, the UN Joint Inspection Unit;
  • Tim Hubbard, Head of Human Genome Analysis, The Wellcome Trust Sanger Institute, UK;
  • Renato da Silveira Martini, Director-General, ITI (National Institute of IT, Brazil).

At a time of growing economic and social disparities within and across countries and regions - coupled with diminishing returns on R&D investments despite stronger intellectual property protection a range of governments and non-governmental groups in technologically advanced and developing countries alike have called for
'"/>

Contact: Louise Bergstrom
unuona@ony.unu.edu
212-963-6387
United Nations University
13-Apr-2006


Page: 1 2 3

Related biology news :

1. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
2. Bright future for nano-sized light source
3. Pointing a finger at the source of fecal bacteria
4. Alien plants attack using resource conservation as weapon, researchers say
5. Supermap of avian flu yields new info on source/spread
6. ESA open-source software supports Germanys TerraSAR-X
7. New agreement helps protect thousands of rice varieties -- the planets most important food source
8. Invitrogen features new scientific online resources at ASCB Meeting
9. Mixed prairie grasses are better biofuel source, U of M study says
10. Ocean sampling yields environmental sources of coral symbionts
11. Forum to explore thorium as abundant source of clean energy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Open source and open medicine take centre stage research symposium

(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... changes to Martine Rothblatt , Ph.D,s compensation program. ... United Therapeutics announced the promotion of Roger Jeffs ... David Zaccardelli , Pharm.D. to Executive Vice President ... Dr. Rothblatt,s title will change from Chairman and Chief ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... 15, 2014 METTLER TOLEDO is ... tool, ParticleView V19 with PVM technology , ... particle vision and measurement tool continuously captures high-resolution ... ParticleView V19 then automatically prepares a report pairing ... size and concentration changes. This compelling blend of ...
(Date:12/15/2014)... SAN DIEGO , Dec. 15, 2014 /PRNewswire/ ... a three-dimensional biology company focused on delivering breakthrough ... by the industry and collaborators of its exVive3D ... was made widely available in full commercial release ... in the field, resulting in several awards for ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
Cached News: